Usage and regulatory acceptance of PBPK models in paediatric drug applications: a review of EMA and FDA public assessment reports PAGE 34 (2026) Abstr 12136 Yu C, Ursino M, Retout S, Chenel M, Comets E, Cleary Y.. ConferenceMIDDPBPK/PBBMPediatricsRegulatory interactionsSpecial/specific populations Pharmetheus Affiliates Chief Research Officer Marylore Chenel See bio
